Zosano Pharma Corporation (ZSAN) Shares Gap Up to $1.07
Shares of Zosano Pharma Corporation (NASDAQ:ZSAN) gapped up prior to trading on Thursday . The stock had previously closed at $1.02, but opened at $1.07. Zosano Pharma Corporation shares last traded at $1.13, with a volume of 8,077,530 shares traded.
Separately, ValuEngine downgraded Zosano Pharma Corporation from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th.
The stock’s market cap is $44.33 million. The company has a 50-day moving average price of $0.91 and a 200-day moving average price of $0.91.
Zosano Pharma Corporation (NASDAQ:ZSAN) last issued its earnings results on Thursday, August 10th. The biotechnology company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.02). During the same quarter in the previous year, the firm posted ($0.54) earnings per share. Analysts anticipate that Zosano Pharma Corporation will post ($0.85) earnings per share for the current year.
Large investors have recently made changes to their positions in the business. Perceptive Advisors LLC acquired a new stake in shares of Zosano Pharma Corporation in the first quarter worth about $950,000. Victory Capital Management Inc. acquired a new stake in shares of Zosano Pharma Corporation in the first quarter worth about $449,000. Endurant Capital Management LP acquired a new stake in shares of Zosano Pharma Corporation in the first quarter worth about $1,135,000. Nexthera Capital LP acquired a new stake in shares of Zosano Pharma Corporation in the first quarter worth about $950,000. Finally, Vanguard Group Inc. lifted its position in shares of Zosano Pharma Corporation by 20.8% in the second quarter. Vanguard Group Inc. now owns 1,217,323 shares of the biotechnology company’s stock worth $1,716,000 after buying an additional 209,251 shares during the last quarter. 22.66% of the stock is owned by institutional investors.
About Zosano Pharma Corporation
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability.
Receive News & Ratings for Zosano Pharma Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zosano Pharma Corporation and related companies with MarketBeat.com's FREE daily email newsletter.